ClinCalc Pro
Menu
Analgesic Pregnancy: C — use at lowest effective dose; neonatal withdrawal risk with prolonged use

Morphine

Brand names: Oramorph, MST Continus, Morphgesic SR

Adult dose

Dose: 2.5–5mg IV (titrate to effect)
Route: IV / IM / SC
Frequency: Every 4h PRN; IV titrate every 5 min
Max: Titrate to effect — no fixed ceiling for acute pain
IV: give 2.5–5mg slowly over 5 min, reassess, repeat as needed. IM/SC: 5–10mg. Reduce by 50% in elderly or opioid-naive patients. Dose in mg/kg: 0.1mg/kg IV.

Paediatric dose

Dose: 0.1 mg/kg
Route: IV (slow over 5 min)
Frequency: Every 4h PRN
Max: 10mg
Concentration: 1 mg/ml

Dose adjustments

Renal

Reduce dose or avoid in CKD — active metabolites (M6G) accumulate. Use fentanyl or oxycodone if GFR <30.

Hepatic

Reduce dose in severe hepatic impairment.

Paediatric weight-based calculator

Clinical pearls

  • Titrate IV morphine in small increments (2.5mg q5 min) — reassess pain and sedation after each dose.
  • Always co-prescribe an antiemetic (cyclizine 50mg or ondansetron 4mg) and laxative.
  • Naloxone duration (<45 min) is SHORTER than morphine — re-sedation risk with larger doses. May require infusion.
  • In CKD3b–5 and dialysis patients: use oxycodone or fentanyl instead — morphine metabolites accumulate causing prolonged respiratory depression.

Contraindications

  • Active respiratory depression
  • Acute asthma attack
  • Paralytic ileus
  • MAO inhibitor use within 14 days

Side effects

  • Nausea and vomiting — prescribe antiemetic prophylactically
  • Constipation — prescribe laxative prophylactically
  • Respiratory depression (dose-dependent)
  • Pruritus (spinal/epidural route particularly)
  • Urinary retention
  • Sedation, hypotension

Interactions

  • CNS depressants: additive sedation and respiratory depression
  • MAOIs: potentially fatal — absolutely contraindicated
  • Naloxone: reversal agent — 0.4mg IV, repeat every 2–3 min
  • Rifampicin: reduces plasma morphine levels

Monitoring

  • Respiratory rate
  • sedation score (RASS or NRS)
  • pain score (NRS)
  • SpO₂

Reference: BNFc; NICE BNF 84; Scottish Palliative Care Guidelines 2024. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.